NIBSC代理
| 参考价 | ¥ 100 |
| 订货量 | ≥1 |
具体成交价以合同协议为准
- 公司名称 深圳远扬医药科技有限公司
- 品牌
- 型号
- 产地
- 厂商性质 生产厂家
- 更新时间 2016/4/13 14:46:25
- 访问次数 428
联系我们时请说明是化工仪器网上看到的信息，谢谢!
NIBSC代理 产品介绍：
美国剑桥同位素CIL是世界上*个生产稳定性同位素标记化合物的生产商，以其的技术雄踞同位素分离领域。20年来，CIL一直研究稳定性同位素与稳定性同位素标记化合物的开发，生产。主要标记性同位素有13C、12C、D、15N、18O和17O，目前已经拥有8000多种标记化合物。CIL的产品均能应用于不同的领域，如物理，化学，生物医学，分析，诊断研究以及环境测试。
NIBSC代理
深圳远扬医药科技有限公司
Contact:何
M.O.B：150 1245 6311
Q.Q：78100 7885
部分产品列表：
| 13/201 | Influenza Antigen B/Massachusetts/02/2079 (Egg derived) |
| 01/503 | Meningococcal serogroup W polysaccharide |
| 07/301 | BCG Vaccine of Russian BCG-I sub-strain(28st WHO Reference Reagent) |
| 95/631 | Interleukin-92 (Human, rDNA derived) |
| 10/208 | Reteplase Reference Material |
| 13/141 | Influenza Antigen B/Massachusetts/02/2019 (Egg derived) |
| 13/147 | Influenza Antigen B/Massachusetts/02/2025 (Egg derived) |
| 13/301 | Polio Anti Sabin type 84 (inactivated) Serum |
| 03/104-037 | HTLV-22 (antibody) Monitor Sample |
| 95/607 | Interleukin-68 (Human, rDNA derived) |
| 10/111 | Reteplase Reference Material |
| 07/350 | BCG Vaccine of Russian BCG-I sub-strain(77st WHO Reference Reagent) |
| 13/260 | Polio Anti Sabin type 43 (inactivated) Serum |
| 01/531 | Meningococcal serogroup W polysaccharide |
| 12/B623-071 | QCRFLUAH1N1QC1-Influenza AH1N1 QC69 |
| 07/340 | BCG Vaccine of Russian BCG-I sub-strain(67st WHO Reference Reagent) |
| 03/104-091 | HTLV-76 (antibody) Monitor Sample |
| 10/167 | Reteplase Reference Material |
| 07/306 | BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent) |
| 07/357 | BCG Vaccine of Russian BCG-I sub-strain(84st WHO Reference Reagent) |
| 07/328 | BCG Vaccine of Russian BCG-I sub-strain(55st WHO Reference Reagent) |
| 12/B623-084 | QCRFLUAH1N1QC1-Influenza AH1N1 QC82 |
| 95/585 | Interleukin-46 (Human, rDNA derived) |
| 03/104-053 | HTLV-38 (antibody) Monitor Sample |
| 95/595 | Interleukin-56 (Human, rDNA derived) |
| 07/336 | BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent) |
| 07/326 | BCG Vaccine of Russian BCG-I sub-strain(53st WHO Reference Reagent) |
| 13/292 | Polio Anti Sabin type 75 (inactivated) Serum |
| 01/491 | Meningococcal serogroup W polysaccharide |
| 13/264 | Polio Anti Sabin type 47 (inactivated) Serum |
| 13/211 | Influenza Antigen B/Massachusetts/02/2089 (Egg derived) |
| 95/554 | Interleukin-15 (Human, rDNA derived) |
| 95/659 | Interleukin-120 (Human, rDNA derived) |
| 07/349 | BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent) |
| 01/528 | Meningococcal serogroup W polysaccharide |
| 13/271 | Polio Anti Sabin type 54 (inactivated) Serum |
| 13/212 | C-Peptide, Human. 67st International Standard. |
| 13/298 | Polio Anti Sabin type 81 (inactivated) Serum |
| 01/450 | Meningococcal serogroup W polysaccharide |
| 10/201 | Reteplase Reference Material |
| 03/104-055 | HTLV-40 (antibody) Monitor Sample |
| 13/163 | Influenza Antigen B/Massachusetts/02/2041 (Egg derived) |
| 13/201 | C-Peptide, Human. 56st International Standard. |
| 10/193 | Reteplase Reference Material |
| 13/206 | Influenza Antigen B/Massachusetts/02/2084 (Egg derived) |
| 12/B623-036 | QCRFLUAH1N1QC1-Influenza AH1N1 QC34 |
| 13/137 | Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
| 95/609 | Interleukin-70 (Human, rDNA derived) |
| 12/B623-017 | QCRFLUAH1N1QC1-Influenza AH1N1 QC15 |
| 01/473 | Meningococcal serogroup W polysaccharide |
| 07/305 | BCG Vaccine of Russian BCG-I sub-strain(32st WHO Reference Reagent) |
| 12/B623-092 | QCRFLUAH1N1QC1-Influenza AH1N1 QC90 |
| 10/184 | Reteplase Reference Material |
| 13/164 | Influenza Antigen B/Massachusetts/02/2042 (Egg derived) |
| 13/255 | Polio Anti Sabin type 38 (inactivated) Serum |
| 10/171 | Reteplase Reference Material |
| 13/242 | C-Peptide, Human. 97st International Standard. |
| 12/B623-059 | QCRFLUAH1N1QC1-Influenza AH1N1 QC57 |
| 13/181 | Influenza Antigen B/Massachusetts/02/2059 (Egg derived) |
| 95/639 | Interleukin-100 (Human, rDNA derived) |
| 13/153 | Influenza Antigen B/Massachusetts/02/2031 (Egg derived) |
| 01/480 | Meningococcal serogroup W polysaccharide |
| 01/482 | Meningococcal serogroup W polysaccharide |
| 13/159 | Influenza Antigen B/Massachusetts/02/2037 (Egg derived) |
| 01/442 | Meningococcal serogroup W polysaccharide |
| 03/104-087 | HTLV-72 (antibody) Monitor Sample |
| 01/513 | Meningococcal serogroup W polysaccharide |
| 13/237 | Polio Anti Sabin type 20 (inactivated) Serum |
| 13/302 | Polio Anti Sabin type 85 (inactivated) Serum |
| 13/228 | Polio Anti Sabin type 11 (inactivated) Serum |
| 10/173 | Reteplase Reference Material |
| 13/209 | Influenza Antigen B/Massachusetts/02/2087 (Egg derived) |
| 13/235 | C-Peptide, Human. 90st International Standard. |
| 13/284 | Polio Anti Sabin type 67 (inactivated) Serum |
| 01/497 | Meningococcal serogroup W polysaccharide |
| 13/200 | C-Peptide, Human. 55st International Standard. |
| 13/148 | Influenza Antigen B/Massachusetts/02/2026 (Egg derived) |
| 01/505 | Meningococcal serogroup W polysaccharide |
| 95/587 | Interleukin-48 (Human, rDNA derived) |
| 12/B623-005 | QCRFLUAH1N1QC1-Influenza AH1N1 QC3 |
| 12/B623-108 | QCRFLUAH1N1QC1-Influenza AH1N1 QC106 |
| 13/303 | Polio Anti Sabin type 86 (inactivated) Serum |
| 12/B623-070 | QCRFLUAH1N1QC1-Influenza AH1N1 QC68 |
| 10/159 | Reteplase Reference Material |
| 03/104-049 | HTLV-34 (antibody) Monitor Sample |
| 10/147 | Reteplase Reference Material |
| 13/142 | Influenza Antigen B/Massachusetts/02/2020 (Egg derived) |
| 03/104-113 | HTLV-98 (antibody) Monitor Sample |
| 13/287 | Polio Anti Sabin type 70 (inactivated) Serum |
| 10/161 | Reteplase Reference Material |
| 95/643 | Interleukin-104 (Human, rDNA derived) |
| 01/444 | Meningococcal serogroup W polysaccharide |
| 03/104-105 | HTLV-90 (antibody) Monitor Sample |
| 13/216 | C-Peptide, Human. 71st International Standard. |
| 07/281 | BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent) |
| 10/149 | Reteplase Reference Material |
| 10/181 | Reteplase Reference Material |
| 07/359 | BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent) |
| 12/B623-082 | QCRFLUAH1N1QC1-Influenza AH1N1 QC80 |
| 03/104-110 | HTLV-95 (antibody) Monitor Sample |
| 10/132 | Reteplase Reference Material |
| 13/171 | C-Peptide, Human. 26st International Standard. |
| 13/248 | C-Peptide, Human. 103st International Standard. |
| 07/325 | BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent) |
| 13/174 | C-Peptide, Human. 29st International Standard. |
| 03/104-081 | HTLV-66 (antibody) Monitor Sample |
| 13/307 | Polio Anti Sabin type 90 (inactivated) Serum |
| 12/B623-045 | QCRFLUAH1N1QC1-Influenza AH1N1 QC43 |
| 07/373 | BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent) |
| 01/506 | Meningococcal serogroup W polysaccharide |
| 13/146 | C-Peptide, Human. 1st International Standard. |
| 10/133 | Reteplase Reference Material |
| 12/B623-081 | QCRFLUAH1N1QC1-Influenza AH1N1 QC79 |
| 95/611 | Interleukin-72 (Human, rDNA derived) |
| 13/187 | Influenza Antigen B/Massachusetts/02/2065 (Egg derived) |
| 12/B623-097 | QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
| 01/469 | Meningococcal serogroup W polysaccharide |
| 03/104-098 | HTLV-83 (antibody) Monitor Sample |
| 95/632 | Interleukin-93 (Human, rDNA derived) |
| 13/190 | Influenza Antigen B/Massachusetts/02/2068 (Egg derived) |
| 13/263 | Polio Anti Sabin type 46 (inactivated) Serum |
| 13/165 | C-Peptide, Human. 20st International Standard. |
| 03/104-028 | HTLV-13 (antibody) Monitor Sample |
| 13/165 | Influenza Antigen B/Massachusetts/02/2043 (Egg derived) |
| 07/364 | BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent) |
| 13/151 | C-Peptide, Human. 6st International Standard. |
| 13/148 | C-Peptide, Human. 3st International Standard. |
| 03/104-057 | HTLV-42 (antibody) Monitor Sample |
| 01/455 | Meningococcal serogroup W polysaccharide |
| 13/179 | C-Peptide, Human. 34st International Standard. |
| 10/200 | Reteplase Reference Material |
| 13/275 | Polio Anti Sabin type 58 (inactivated) Serum |
| 01/467 | Meningococcal serogroup W polysaccharide |
| 13/267 | Polio Anti Sabin type 50 (inactivated) Serum |
| 01/509 | Meningococcal serogroup W polysaccharide |
| 01/460 | Meningococcal serogroup W polysaccharide |
| 95/589 | Interleukin-50 (Human, rDNA derived) |
| 13/266 | Polio Anti Sabin type 49 (inactivated) Serum |
| 13/253 | C-Peptide, Human. 108st International Standard. |
| 95/593 | Interleukin-54 (Human, rDNA derived) |
| 13/244 | C-Peptide, Human. 99st International Standard. |
| 12/B623-068 | QCRFLUAH1N1QC1-Influenza AH1N1 QC66 |
| 07/365 | BCG Vaccine of Russian BCG-I sub-strain(92st WHO Reference Reagent) |
| 13/245 | C-Peptide, Human. 100st International Standard. |
| 95/572 | Interleukin-33 (Human, rDNA derived) |
| 12/B623-053 | QCRFLUAH1N1QC1-Influenza AH1N1 QC51 |
| 13/168 | Influenza Antigen B/Massachusetts/02/2046 (Egg derived) |
| 01/459 | Meningococcal serogroup W polysaccharide |
| 07/366 | BCG Vaccine of Russian BCG-I sub-strain(93st WHO Reference Reagent) |
| 95/564 | Interleukin-25 (Human, rDNA derived) |
| 03/104-102 | HTLV-87 (antibody) Monitor Sample |
| 13/217 | Influenza Antigen B/Massachusetts/02/2095 (Egg derived) |
| 01/472 | Meningococcal serogroup W polysaccharide |
| 07/379 | BCG Vaccine of Russian BCG-I sub-strain(106st WHO Reference Reagent) |
| 01/433 | Meningococcal serogroup W polysaccharide |
| 01/502 | Meningococcal serogroup W polysaccharide |
| 13/269 | Polio Anti Sabin type 52 (inactivated) Serum |
| 07/302 | BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent) |
| 03/104-016 | HTLV-1 (antibody) Monitor Sample |
| 10/155 | Reteplase Reference Material |
| 13/231 | C-Peptide, Human. 86st International Standard. |
| 03/104-022 | HTLV-7 (antibody) Monitor Sample |
| 07/277 | BCG Vaccine of Russian BCG-I sub-strain(4st WHO Reference Reagent) |
| 03/104-123 | HTLV-108 (antibody) Monitor Sample |
| 13/205 | C-Peptide, Human. 60st International Standard. |
| 13/306 | Polio Anti Sabin type 89 (inactivated) Serum |
| 07/362 | BCG Vaccine of Russian BCG-I sub-strain(89st WHO Reference Reagent) |
| 01/441 | Meningococcal serogroup W polysaccharide |
| 13/261 | Polio Anti Sabin type 44 (inactivated) Serum |
| 10/156 | Reteplase Reference Material |
| 95/579 | Interleukin-40 (Human, rDNA derived) |
| 95/598 | Interleukin-59 (Human, rDNA derived) |
| 10/158 | Reteplase Reference Material |
| 07/323 | BCG Vaccine of Russian BCG-I sub-strain(50st WHO Reference Reagent) |
| 07/291 | BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent) |
| 01/468 | Meningococcal serogroup W polysaccharide |
| 13/236 | C-Peptide, Human. 91st International Standard. |
| 01/447 | Meningococcal serogroup W polysaccharide |
| 95/650 | Interleukin-111 (Human, rDNA derived) |
| 13/193 | C-Peptide, Human. 48st International Standard. |
| 03/104-082 | HTLV-67 (antibody) Monitor Sample |
| 13/214 | Influenza Antigen B/Massachusetts/02/2092 (Egg derived) |
| 03/104-067 | HTLV-52 (antibody) Monitor Sample |
| 03/104-107 | HTLV-92 (antibody) Monitor Sample |
| 13/322 | Polio Anti Sabin type 105 (inactivated) Serum |
| 13/212 | Influenza Antigen B/Massachusetts/02/2090 (Egg derived) |
| 13/234 | Polio Anti Sabin type 17 (inactivated) Serum |
| 10/138 | Reteplase Reference Material |
| 13/166 | C-Peptide, Human. 21st International Standard. |
| 13/238 | Polio Anti Sabin type 21 (inactivated) Serum |
| 01/437 | Meningococcal serogroup W polysaccharide |
| 13/237 | C-Peptide, Human. 92st International Standard. |
| 03/104-117 | HTLV-102 (antibody) Monitor Sample |
| 03/104-122 | HTLV-107 (antibody) Monitor Sample |
| 07/356 | BCG Vaccine of Russian BCG-I sub-strain(83st WHO Reference Reagent) |
| 07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
| 13/178 | C-Peptide, Human. 33st International Standard. |
| 12/B623-096 | QCRFLUAH1N1QC1-Influenza AH1N1 QC94 |
| 01/499 | Meningococcal serogroup W polysaccharide |
| 13/160 | Influenza Antigen B/Massachusetts/02/2038 (Egg derived) |
| 03/104-086 | HTLV-71 (antibody) Monitor Sample |
| 01/443 | Meningococcal serogroup W polysaccharide |
| 12/B623-094 | QCRFLUAH1N1QC1-Influenza AH1N1 QC92 |
| 12/B623-021 | QCRFLUAH1N1QC1-Influenza AH1N1 QC19 |
| 01/440 | Meningococcal serogroup W polysaccharide |
| 13/268 | Polio Anti Sabin type 51 (inactivated) Serum |
| 03/104-029 | HTLV-14 (antibody) Monitor Sample |
| 13/241 | Influenza Antigen B/Massachusetts/02/2119 (Egg derived) |
| 95/617 | Interleukin-78 (Human, rDNA derived) |
| 03/104-040 | HTLV-25 (antibody) Monitor Sample |
| 13/249 | C-Peptide, Human. 104st International Standard. |
| 01/483 | Meningococcal serogroup W polysaccharide |
| 10/125 | Reteplase Reference Material |
| 13/241 | Polio Anti Sabin type 24 (inactivated) Serum |
| 07/363 | BCG Vaccine of Russian BCG-I sub-strain(90st WHO Reference Reagent) |
| 07/343 | BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent) |
| 01/446 | Meningococcal serogroup W polysaccharide |
| 95/636 | Interleukin-97 (Human, rDNA derived) |
| 13/155 | C-Peptide, Human. 10st International Standard. |
| 12/B623-089 | QCRFLUAH1N1QC1-Influenza AH1N1 QC87 |
| 13/240 | Influenza Antigen B/Massachusetts/02/2118 (Egg derived) |
| 12/B623-031 | QCRFLUAH1N1QC1-Influenza AH1N1 QC29 |
| 95/613 | Interleukin-74 (Human, rDNA derived) |
| 95/610 | Interleukin-71 (Human, rDNA derived) |
| 13/178 | Influenza Antigen B/Massachusetts/02/2056 (Egg derived) |
| 07/342 | BCG Vaccine of Russian BCG-I sub-strain(69st WHO Reference Reagent) |
| 01/478 | Meningococcal serogroup W polysaccharide |
| 01/511 | Meningococcal serogroup W polysaccharide |
| 13/150 | C-Peptide, Human. 5st International Standard. |
| 13/253 | Polio Anti Sabin type 36 (inactivated) Serum |
| 10/121 | Reteplase Reference Material |
| 13/182 | C-Peptide, Human. 37st International Standard. |
| 12/B623-073 | QCRFLUAH1N1QC1-Influenza AH1N1 QC71 |
| 12/B623-057 | QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
| 13/321 | Polio Anti Sabin type 104 (inactivated) Serum |
| 01/498 | Meningococcal serogroup W polysaccharide |
| 01/465 | Meningococcal serogroup W polysaccharide |
| 95/642 | Interleukin-103 (Human, rDNA derived) |
| 10/169 | Reteplase Reference Material |
| 95/625 | Interleukin-86 (Human, rDNA derived) |
| 13/219 | Influenza Antigen B/Massachusetts/02/2097 (Egg derived) |
| 13/210 | C-Peptide, Human. 65st International Standard. |
| 13/237 | Influenza Antigen B/Massachusetts/02/2115 (Egg derived) |
| 03/104-084 | HTLV-69 (antibody) Monitor Sample |
| 07/318 | BCG Vaccine of Russian BCG-I sub-strain(45st WHO Reference Reagent) |
| 95/580 | Interleukin-41 (Human, rDNA derived) |
| 10/130 | Reteplase Reference Material |
| 12/B623-034 | QCRFLUAH1N1QC1-Influenza AH1N1 QC32 |
| 95/583 | Interleukin-44 (Human, rDNA derived) |
| 07/341 | BCG Vaccine of Russian BCG-I sub-strain(68st WHO Reference Reagent) |
| 12/B623-051 | QCRFLUAH1N1QC1-Influenza AH1N1 QC49 |
| 12/B623-069 | QCRFLUAH1N1QC1-Influenza AH1N1 QC67 |
| 13/198 | Influenza Antigen B/Massachusetts/02/2076 (Egg derived) |
| 13/251 | Polio Anti Sabin type 34 (inactivated) Serum |
| 95/578 | Interleukin-39 (Human, rDNA derived) |
| 10/187 | Reteplase Reference Material |
| 12/B623-076 | QCRFLUAH1N1QC1-Influenza AH1N1 QC74 |
| 01/532 | Meningococcal serogroup W polysaccharide |
| 03/104-034 | HTLV-19 (antibody) Monitor Sample |
| 12/B623-042 | QCRFLUAH1N1QC1-Influenza AH1N1 QC40 |
| 03/104-088 | HTLV-73 (antibody) Monitor Sample |
| 07/367 | BCG Vaccine of Russian BCG-I sub-strain(94st WHO Reference Reagent) |
| 95/597 | Interleukin-58 (Human, rDNA derived) |
| 12/B623-041 | QCRFLUAH1N1QC1-Influenza AH1N1 QC39 |
| 13/157 | C-Peptide, Human. 12st International Standard. |
| 13/234 | Influenza Antigen B/Massachusetts/02/2112 (Egg derived) |
| 13/202 | C-Peptide, Human. 57st International Standard. |
| 13/153 | C-Peptide, Human. 8st International Standard. |
| 95/603 | Interleukin-64 (Human, rDNA derived) |
| 10/123 | Reteplase Reference Material |
| 13/227 | C-Peptide, Human. 82st International Standard. |
| 01/524 | Meningococcal serogroup W polysaccharide |
| 13/209 | C-Peptide, Human. 64st International Standard. |
| 95/626 | Interleukin-87 (Human, rDNA derived) |
| 95/657 | Interleukin-118 (Human, rDNA derived) |
| 13/251 | C-Peptide, Human. 106st International Standard. |
| 03/104-042 | HTLV-27 (antibody) Monitor Sample |
| 01/516 | Meningococcal serogroup W polysaccharide |
| 03/104-051 | HTLV-36 (antibody) Monitor Sample |
| 01/490 | Meningococcal serogroup W polysaccharide |
| 95/623 | Interleukin-84 (Human, rDNA derived) |
| 13/252 | Polio Anti Sabin type 35 (inactivated) Serum |
| 13/278 | Polio Anti Sabin type 61 (inactivated) Serum |
| 95/630 | Interleukin-91 (Human, rDNA derived) |
| 10/128 | Reteplase Reference Material |
| 13/172 | C-Peptide, Human. 27st International Standard. |
| 07/378 | BCG Vaccine of Russian BCG-I sub-strain(105st WHO Reference Reagent) |
| 01/448 | Meningococcal serogroup W polysaccharide |
| 07/313 | BCG Vaccine of Russian BCG-I sub-strain(40st WHO Reference Reagent) |
| 13/304 | Polio Anti Sabin type 87 (inactivated) Serum |
| 13/173 | C-Peptide, Human. 28st International Standard. |
| 12/B623-098 | QCRFLUAH1N1QC1-Influenza AH1N1 QC96 |
| 13/257 | Polio Anti Sabin type 40 (inactivated) Serum |
| 01/526 | Meningococcal serogroup W polysaccharide |
| 12/B623-055 | QCRFLUAH1N1QC1-Influenza AH1N1 QC53 |
| 13/185 | C-Peptide, Human. 40st International Standard. |
| 12/B623-072 | QCRFLUAH1N1QC1-Influenza AH1N1 QC70 |
| 12/B623-032 | QCRFLUAH1N1QC1-Influenza AH1N1 QC30 |
| 03/104-099 | HTLV-84 (antibody) Monitor Sample |
| 13/161 | C-Peptide, Human. 16st International Standard. |
| 10/179 | Reteplase Reference Material |
| 12/B623-048 | QCRFLUAH1N1QC1-Influenza AH1N1 QC46 |
| 01/445 | Meningococcal serogroup W polysaccharide |
| 10/122 | Reteplase Reference Material |
| 13/235 | Polio Anti Sabin type 18 (inactivated) Serum |
| 01/487 | Meningococcal serogroup W polysaccharide |
| 13/239 | C-Peptide, Human. 94st International Standard. |
| 13/296 | Polio Anti Sabin type 79 (inactivated) Serum |
| 13/289 | Polio Anti Sabin type 72 (inactivated) Serum |
| 13/280 | Polio Anti Sabin type 63 (inactivated) Serum |
| 13/227 | Polio Anti Sabin type 10 (inactivated) Serum |
| 07/309 | BCG Vaccine of Russian BCG-I sub-strain(36st WHO Reference Reagent) |
| 13/214 | C-Peptide, Human. 69st International Standard. |
| 03/104-033 | HTLV-18 (antibody) Monitor Sample |
| 12/B623-023 | QCRFLUAH1N1QC1-Influenza AH1N1 QC21 |
| 13/248 | Polio Anti Sabin type 31 (inactivated) Serum |
| 95/653 | Interleukin-114 (Human, rDNA derived) |
| 03/104-046 | HTLV-31 (antibody) Monitor Sample |
| 03/104-063 | HTLV-48 (antibody) Monitor Sample |
| 10/180 | Reteplase Reference Material |
| 07/300 | BCG Vaccine of Russian BCG-I sub-strain(27st WHO Reference Reagent) |
| 13/197 | Influenza Antigen B/Massachusetts/02/2075 (Egg derived) |
| 13/144 | Influenza Antigen B/Massachusetts/02/2022 (Egg derived) |
| 13/223 | Influenza Antigen B/Massachusetts/02/2101 (Egg derived) |
| 12/B623-014 | QCRFLUAH1N1QC1-Influenza AH1N1 QC12 |
| 13/152 | C-Peptide, Human. 7st International Standard. |
| 10/112 | Reteplase Reference Material |
| 03/104-104 | HTLV-89 (antibody) Monitor Sample |
| 12/B623-063 | QCRFLUAH1N1QC1-Influenza AH1N1 QC61 |
| 13/151 | Influenza Antigen B/Massachusetts/02/2029 (Egg derived) |
| 07/337 | BCG Vaccine of Russian BCG-I sub-strain(64st WHO Reference Reagent) |
| 95/604 | Interleukin-65 (Human, rDNA derived) |
| 95/581 | Interleukin-42 (Human, rDNA derived) |
| 95/638 | Interleukin-99 (Human, rDNA derived) |
| 12/B623-012 | QCRFLUAH1N1QC1-Influenza AH1N1 QC10 |
| 10/176 | Reteplase Reference Material |
| 13/245 | Polio Anti Sabin type 28 (inactivated) Serum |
| 10/207 | Reteplase Reference Material |
| 13/315 | Polio Anti Sabin type 98 (inactivated) Serum |
| 13/232 | Influenza Antigen B/Massachusetts/02/2110 (Egg derived) |
| 03/104-048 | HTLV-33 (antibody) Monitor Sample |
| 12/B623-105 | QCRFLUAH1N1QC1-Influenza AH1N1 QC103 |
| 03/104-092 | HTLV-77 (antibody) Monitor Sample |
| 95/614 | Interleukin-75 (Human, rDNA derived) |
| 01/466 | Meningococcal serogroup W polysaccharide |
| 01/530 | Meningococcal serogroup W polysaccharide |
| 13/240 | Polio Anti Sabin type 23 (inactivated) Serum |
| 10/211 | Reteplase Reference Material |
| 13/252 | C-Peptide, Human. 107st International Standard. |
| 10/206 | Reteplase Reference Material |
| 13/235 | Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
| 12/B623-102 | QCRFLUAH1N1QC1-Influenza AH1N1 QC100 |
| 13/319 | Polio Anti Sabin type 102 (inactivated) Serum |
| 01/485 | Meningococcal serogroup W polysaccharide |
| 01/436 | Meningococcal serogroup W polysaccharide |
| 03/104-038 | HTLV-23 (antibody) Monitor Sample |
| 13/223 | Polio Anti Sabin type 6 (inactivated) Serum |
| 03/104-096 | HTLV-81 (antibody) Monitor Sample |
| 03/104-119 | HTLV-104 (antibody) Monitor Sample |
| 01/515 | Meningococcal serogroup W polysaccharide |
| 07/312 | BCG Vaccine of Russian BCG-I sub-strain(39st WHO Reference Reagent) |
| 95/621 | Interleukin-82 (Human, rDNA derived) |
| 95/596 | Interleukin-57 (Human, rDNA derived) |
| 03/104-120 | HTLV-105 (antibody) Monitor Sample |
| 13/225 | Influenza Antigen B/Massachusetts/02/2103 (Egg derived) |
| 95/608 | Interleukin-69 (Human, rDNA derived) |
| 13/224 | Influenza Antigen B/Massachusetts/02/2102 (Egg derived) |
| 10/165 | Reteplase Reference Material |
| 13/136 | Influenza Antigen B/Massachusetts/02/2014 (Egg derived) |
| 13/194 | C-Peptide, Human. 49st International Standard. |
| 13/191 | C-Peptide, Human. 46st International Standard. |
| 13/225 | C-Peptide, Human. 80st International Standard. |
| 03/104-083 | HTLV-68 (antibody) Monitor Sample |
| 95/655 | Interleukin-116 (Human, rDNA derived) |
| 13/305 | Polio Anti Sabin type 88 (inactivated) Serum |
| 13/145 | Influenza Antigen B/Massachusetts/02/2023 (Egg derived) |
| 07/275 | BCG Vaccine of Russian BCG-I sub-strain(2st WHO Reference Reagent) |
| 13/177 | C-Peptide, Human. 32st International Standard. |
| 07/369 | BCG Vaccine of Russian BCG-I sub-strain(96st WHO Reference Reagent) |
| 10/139 | Reteplase Reference Material |
| 10/119 | Reteplase Reference Material |
| 01/496 | Meningococcal serogroup W polysaccharide |
| 13/221 | Polio Anti Sabin type 4 (inactivated) Serum |
| 07/278 | BCG Vaccine of Russian BCG-I sub-strain(5st WHO Reference Reagent) |
| 01/533 | Meningococcal serogroup W polysaccharide |
| 03/104-050 | HTLV-35 (antibody) Monitor Sample |
| 13/273 | Polio Anti Sabin type 56 (inactivated) Serum |
| 03/104-021 | HTLV-6 (antibody) Monitor Sample |
| 03/104-106 | HTLV-91 (antibody) Monitor Sample |
| 95/612 | Interleukin-73 (Human, rDNA derived) |
| 10/129 | Reteplase Reference Material |
| 01/501 | Meningococcal serogroup W polysaccharide |
| 12/B623-009 | QCRFLUAH1N1QC1-Influenza AH1N1 QC7 |
| 95/622 | Interleukin-83 (Human, rDNA derived) |
| 07/276 | BCG Vaccine of Russian BCG-I sub-strain(3st WHO Reference Reagent) |
| 07/315 | BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
| 13/217 | C-Peptide, Human. 72st International Standard. |
| 13/229 | Influenza Antigen B/Massachusetts/02/2107 (Egg derived) |
| 07/280 | BCG Vaccine of Russian BCG-I sub-strain(7st WHO Reference Reagent) |
| 13/211 | C-Peptide, Human. 66st International Standard. |
| 10/166 | Reteplase Reference Material |
| 13/239 | Influenza Antigen B/Massachusetts/02/2117 (Egg derived) |
| 10/196 | Reteplase Reference Material |
| 13/207 | C-Peptide, Human. 62st International Standard. |
| 95/629 | Interleukin-90 (Human, rDNA derived) |
| 03/104-020 | HTLV-5 (antibody) Monitor Sample |
| 13/191 | Influenza Antigen B/Massachusetts/02/2069 (Egg derived) |
| 13/236 | Influenza Antigen B/Massachusetts/02/2114 (Egg derived) |
| 95/647 | Interleukin-108 (Human, rDNA derived) |
| 95/560 | Interleukin-21 (Human, rDNA derived) |
| 12/B623-047 | QCRFLUAH1N1QC1-Influenza AH1N1 QC45 |
| 07/279 | BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent) |
| 07/338 | BCG Vaccine of Russian BCG-I sub-strain(65st WHO Reference Reagent) |
| 13/246 | Polio Anti Sabin type 29 (inactivated) Serum |
| 13/159 | C-Peptide, Human. 14st International Standard. |
| 13/199 | Influenza Antigen B/Massachusetts/02/2077 (Egg derived) |
| 01/476 | Meningococcal serogroup W polysaccharide |
| 95/557 | Interleukin-18 (Human, rDNA derived) |
| 13/175 | C-Peptide, Human. 30st International Standard. |
| 13/186 | C-Peptide, Human. 41st International Standard. |
| 03/104-060 | HTLV-45 (antibody) Monitor Sample |
| 07/330 | BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent) |
| 13/157 | Influenza Antigen B/Massachusetts/02/2035 (Egg derived) |
| 13/224 | C-Peptide, Human. 79st International Standard. |
| 12/B623-101 | QCRFLUAH1N1QC1-Influenza AH1N1 QC99 |
| 07/380 | BCG Vaccine of Russian BCG-I sub-strain(107st WHO Reference Reagent) |
| 10/145 | Reteplase Reference Material |
| 01/521 | Meningococcal serogroup W polysaccharide |
| 12/B623-038 | QCRFLUAH1N1QC1-Influenza AH1N1 QC36 |
| 13/149 | C-Peptide, Human. 4st International Standard. |
| 13/247 | Polio Anti Sabin type 30 (inactivated) Serum |
| 10/146 | Reteplase Reference Material |
| 12/B623-087 | QCRFLUAH1N1QC1-Influenza AH1N1 QC85 |
| 07/346 | BCG Vaccine of Russian BCG-I sub-strain(73st WHO Reference Reagent) |
| 10/210 | Reteplase Reference Material |
| 13/272 | Polio Anti Sabin type 55 (inactivated) Serum |
| 13/161 | Influenza Antigen B/Massachusetts/02/2039 (Egg derived) |
| 13/166 | Influenza Antigen B/Massachusetts/02/2044 (Egg derived) |
| 12/B623-065 | QCRFLUAH1N1QC1-Influenza AH1N1 QC63 |
| 95/565 | Interleukin-26 (Human, rDNA derived) |
| 10/168 | Reteplase Reference Material |
| 07/283 | BCG Vaccine of Russian BCG-I sub-strain(10st WHO Reference Reagent) |
| 13/160 | C-Peptide, Human. 15st International Standard. |
| 13/277 | Polio Anti Sabin type 60 (inactivated) Serum |
| 07/351 | BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent) |
| 10/142 | Reteplase Reference Material |
| 10/148 | Reteplase Reference Material |
| 07/322 | BCG Vaccine of Russian BCG-I sub-strain(49st WHO Reference Reagent) |
| 07/376 | BCG Vaccine of Russian BCG-I sub-strain(103st WHO Reference Reagent) |
| 12/B623-077 | QCRFLUAH1N1QC1-Influenza AH1N1 QC75 |
| 03/104-019 | HTLV-4 (antibody) Monitor Sample |
| 10/175 | Reteplase Reference Material |
| 13/163 | C-Peptide, Human. 18st International Standard. |
| 13/310 | Polio Anti Sabin type 93 (inactivated) Serum |
| 10/144 | Reteplase Reference Material |
| 10/135 | Reteplase Reference Material |
| 01/500 | Meningococcal serogroup W polysaccharide |
| 95/618 | Interleukin-79 (Human, rDNA derived) |
| 13/146 | Influenza Antigen B/Massachusetts/02/2024 (Egg derived) |
| 01/453 | Meningococcal serogroup W polysaccharide |
| 01/470 | Meningococcal serogroup W polysaccharide |
| 12/B623-035 | QCRFLUAH1N1QC1-Influenza AH1N1 QC33 |
| 01/461 | Meningococcal serogroup W polysaccharide |
| 10/104 | Reteplase Reference Material |
| 07/335 | BCG Vaccine of Russian BCG-I sub-strain(62st WHO Reference Reagent) |
| 13/243 | Polio Anti Sabin type 26 (inactivated) Serum |
| 10/120 | Reteplase Reference Material |
| 12/B623-095 | QCRFLUAH1N1QC1-Influenza AH1N1 QC93 |
| 95/637 | Interleukin-98 (Human, rDNA derived) |
| 01/439 | Meningococcal serogroup W polysaccharide |
| 12/B623-028 | QCRFLUAH1N1QC1-Influenza AH1N1 QC26 |
| 03/104-079 | HTLV-64 (antibody) Monitor Sample |
| 12/B623-010 | QCRFLUAH1N1QC1-Influenza AH1N1 QC8 |
| 07/311 | BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent) |
| 13/323 | Polio Anti Sabin type 106 (inactivated) Serum |
| 13/297 | Polio Anti Sabin type 80 (inactivated) Serum |
| 13/312 | Polio Anti Sabin type 95 (inactivated) Serum |
| 01/520 | Meningococcal serogroup W polysaccharide |
| 01/492 | Meningococcal serogroup W polysaccharide |
| 03/104-030 | HTLV-15 (antibody) Monitor Sample |
| 13/281 | Polio Anti Sabin type 64 (inactivated) Serum |
| 01/462 | Meningococcal serogroup W polysaccharide |
| 95/594 | Interleukin-55 (Human, rDNA derived) |
| 10/182 | Reteplase Reference Material |
| 12/B623-091 | QCRFLUAH1N1QC1-Influenza AH1N1 QC89 |
| 13/173 | Influenza Antigen B/Massachusetts/02/2051 (Egg derived) |
采购中心
化工仪器网